Accelerating response to antidepressant treatment in depression: A review and clinical suggestions

被引:54
|
作者
Nakajima, Shinichiro
Suzuki, Takefumi [2 ,3 ]
Watanabe, Koichiro
Kashima, Haruo
Uchida, Hiroyuki [1 ,2 ]
机构
[1] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan
[2] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
Antidepressant; Early non-response; Major depressive disorder; Predictor; Switching; SEROTONIN REUPTAKE INHIBITOR; TREATING MAJOR DEPRESSION; EARLY IMPROVEMENT; PROMOTER POLYMORPHISM; DOUBLE-BLIND; METAANALYSIS; FLUOXETINE; DISORDER; EFFICACY; AUGMENTATION;
D O I
10.1016/j.pnpbp.2009.12.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8 weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2 weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2 weeks. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [41] Persistence and compliance to antidepressant treatment in patients with depression: A chart review
    Sawada, Norifusa
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Watanabe, Koichiro
    Kikuchi, Toshiaki
    Handa, Takashi
    Kashima, Haruo
    BMC PSYCHIATRY, 2009, 9
  • [42] Persistence and compliance to antidepressant treatment in patients with depression: A chart review
    Norifusa Sawada
    Hiroyuki Uchida
    Takefumi Suzuki
    Koichiro Watanabe
    Toshiaki Kikuchi
    Takashi Handa
    Haruo Kashima
    BMC Psychiatry, 9
  • [43] Persistence and compliance to antidepressant treatment in patients with depression: a chart review
    Sawada, N.
    Uchida, H.
    Suzuki, T.
    Watanabe, K.
    Kikuchi, T.
    Nio, S.
    Tsuboi, T.
    Handa, T.
    Kashima, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S370 - S371
  • [44] Antidepressant treatment of depression in children and adolescents: a systematic review and dose-response meta-analysis
    Zhang, Yuan
    Gao, Yiyuan
    Li, Xuelian
    Zou, Yazhu
    Ye, Yu
    Zou, Zhili
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2025,
  • [45] Harm Avoidance as a Mediator of Treatment Response to Antidepressant Treatment of Patients with Major Depression
    Quilty, Lena C.
    Godfrey, Kathryn M.
    Kennedy, Sidney H.
    Bagby, R. Michael
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2010, 79 (02) : 116 - 122
  • [46] Does Pain Interfere with Antidepressant Depression Treatment Response and Remission in Patients with Depression and Pain? An Evidence-Based Structured Review
    Fishbain, David A.
    Cole, Brandly
    Lewis, John E.
    Gao, Jinrun
    PAIN MEDICINE, 2014, 15 (09) : 1522 - 1539
  • [47] Preclinical Sex Differences in Depression and Antidepressant Response: Implications for Clinical Research
    Kokras, Nikolaos
    Dalla, Christina
    JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (1-2) : 731 - 736
  • [48] A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
    Janssen, Debbie G. A.
    Caniato, Riccardo N.
    Verster, Joris C.
    Baune, Bernhard T.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (03) : 201 - 215
  • [49] Antidepressant pharmacotherapy in old-age depression—a review and clinical approach
    Nathalie Pruckner
    Vjera Holthoff-Detto
    European Journal of Clinical Pharmacology, 2017, 73 : 661 - 667
  • [50] Antidepressant treatment of depression in dementia
    Draper, Brian
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 (07): : 676 - 677